Addressing the emotional component of post-stroke pain
Andre Machado, MD, PhD, of Cleveland Clinic’s Neurological Institute, has completed the first human clinical trial of deep brain stimulation (DBS) for refractive thalamic pain syndrome. The study is also the first controlled study to assess the effects of DBS on the affective or emotional sphere of pain. Thalamic pain syndrome is a chronic condition that is usually caused by a stroke. Patients describe their pain as a constant burning or aching sensation, disabling in nature. Dr. Machado targeted a particular area of the brain that is a key node in the networks that process mood and behavior. The study was carried out entirely at Cleveland Clinic with funding from the NIH Director’s New Innovator Award. “Chronic pain is not only a somatosensory phenomenon,” says Dr. Machado. “Affective and cognitive spheres are equally important in the experience of pain and suffering. Our approach aims to alleviate the affective sphere of pain and thus reduce pain-related disability.”
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement
Advertisement
Real-world claims data and tissue culture studies set the stage for randomized clinical testing
New grant-funded investigation illustrates impact and reach of Cleveland Clinic Brain Study
How the new longitudinal investigation could become the Framingham Heart Study of brain health
Pilot findings show good patient acceptance and safety, early hints of efficacy
Study finds high prevalence of symptoms, willingness to seek treatment
Panel outlines research priorities around a promising alternative to imaging markers
Suspected factors include antithrombotic intensity, time on device, presence of thrombocytopenia
Preclinical studies will assess whether method developed for stroke recovery curbs deficits after brain injury